|Publication number||US7250298 B2|
|Application number||US 11/100,988|
|Publication date||Jul 31, 2007|
|Filing date||Apr 7, 2005|
|Priority date||Apr 7, 2004|
|Also published as||EP1732944A1, EP1732944B1, US7671185, US7910714, US20060008878, US20070244298, US20100184954, WO2005100387A1|
|Publication number||100988, 11100988, US 7250298 B2, US 7250298B2, US-B2-7250298, US7250298 B2, US7250298B2|
|Inventors||Benjamin S. Glick, Brooke Bevis, Daniel E. Strongin, David Baker, Michelle Scalley-Kim|
|Original Assignee||The University Of Chicago, The University Of Washington|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (96), Non-Patent Citations (99), Referenced by (9), Classifications (17), Legal Events (5)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application claims the benefit of U.S. Provisional Application No. 60/560,340, filed Apr. 7, 2004, which is incorporated by reference in its entirety.
This invention was made with government support under MCB-9875939, awarded by the National Science Foundation, and under RPG-00-245-01-CSM, awarded by the American Cancer Society. The government has certain rights in the invention.
Fluorescent proteins such as green fluorescent protein (GFP) are invaluable tools used in pure and applied research. Although fluorescent proteins have been widely available for a relatively short time, they have had an important impact on biomedical research, contributing to our understanding of basic cellular and developmental processes that underlie health and disease. GFP and its relatives are widely used for medically-oriented research. For example, GFP has been used to analyze bacterial gene expression during infection, to visualize tumor cell behavior during metastasis, and to monitor GFP fusion proteins in gene therapy studies. Fluorescent proteins are also useful in high-throughput screens for drug discovery.
A red fluorescent protein produced by the coral Discosoma and designated DsRed (wild-type DsRed) is potentially useful as a fluorescent reporter protein or as a fusion tag. A red fluorescent protein is particularly attractive because of its suitability for use in conjunction with fluorescent proteins having different fluorescent properties, such as GFP. However, wild-type DsRed suffers from certain drawbacks.
First, the maturation process that yields the red fluorophore is slow, with a half-time of ˜12 h at 37° C. Second, wild-type DsRed occurs as a stable tetramer of four very similar polypeptides, which makes its use as a fluorescent reporter in a fusion protein problematic. For example, tetramerization of the DsRed fusion protein may interfere with or perturb the function or localization of the protein. In addition, DsRed tetramers undergo higher-order aggregation. Fusion of DsRed to membrane proteins or to oligomeric proteins often produces large aggregates. Efforts to develop variants of DsRed having a reduced tendency to form tetramers have met with limited success, in that the variants suffer from disadvantages such as undesirable shifts in fluorescence or more rapid photobleaching.
There is, therefore, ongoing interest in developing new fluorescent protein labels with improved characteristics as experimental and clinical tools.
The present invention provides polynucleotide encoding a variant polypeptide of wild-type DsRed or the rapidly maturing DsRed.T4, a tetrameric variant that has the substitutions described herein below. The variant polypeptide has reduced oligomerization relative wild-type DsRed and has a fluorescence spectra similar to the fluorescence spectra of the wild-type DsRed, the variant polypeptide comprising the amino acid substitutions K83M, K163H, and Y193H and further comprises at least of one amino acid substitutions E26Y, K92T, V96S, T106E, T108Q, 1125K, S131A, I180V, and M182K.
In another aspect, the invention provides isolated polynucleotides encoding a variant polypeptide of the rapidly DsRed.T4 and exhibiting reduced oligomerization relative to DsRed.T4 and detectable red fluorescence, the variant polypeptide comprising at least one of amino substitutions K83M or K83L; K163Q, K163M, or K163H; and Y193H, and further comprising at least three amino acid substitutions selected from E26Y, K92T, V96S, T106E, T108Q, I125K, S131A, I180V, and M182K; and further comprising at least three amino acid substitutions selected from the group consisting of R149K, R153Q, H162S, L174T, E176D, Y192N, R216H, H222S, L223G, and F224S.
In other aspects, the invention provides genetic constructs comprising the polynucleotides, vectors comprising the constructs, cells comprising the constructs, variant polypeptides encoded by the polynucleotides, and methods of obtaining expression of the polynucleotides.
The present invention provides polypeptide variants of wild-type Discosoma sp. red fluorescent protein (DsRed). Wild-type DsRed forms oligomers (e.g., dimers or tetramers) under physiologic conditions, which, in the native polypeptide, appears to play a role in its fluorescence activity. A coding sequence for wild-type Discosoma sp. red fluorescent protein (DsRed) is shown in SEQ ID NO:1, and the amino acid sequence of DsRed is shown in SEQ ID NO:2. The polypeptide variants of the present invention have a reduced tendency to oligomerize relative to wild-type DsRed. This reduced tendency to oligomerize may be assessed by any suitable means, whether in vivo or in vitro, as described below.
Polypeptide variants were genetically engineered, as described in detail below, by altering a sequence encoding a rapidly maturing tetrameric variant of wild-type DsRed, designated DsRed.T4 (SEQ ID NO:3). DsRed.T4 is described in further detail in co-pending U.S. patent application Ser. No. 10/844,064, which is incorporated by reference in its entirety. Relative to the wild-type DsRed of SEQ ID NO:2, DsRed.T4 contains the following substitutions:
Relative to either wild-type DsRed or DsRedT4, the polypeptides of the present invention exhibit a reduced tendency to oligomerize or form tetramers, and exist primarily as monomers under physiologic conditions. The polypeptide variants exhibit detectable red fluorescence. By “detectable red fluorescence” it is meant that the fluorescence overlaps the emission spectra of wild-type DsRed is distinguishable over background. Preferably, the emission spectra is similar to that of wild-type DsRed.
To develop monomeric DsRed variants, a polynucleotide sequence encoding DsRedT4 was modified using the following general approach. As one skilled in the art will appreciate, one could also begin with a polynucleotide encoding another DsRed, for example, wild-type DsRed.
Mutations were introduced into a polynucleotide sequence encoding DsRedT4 to disrupt the tetramerization interfaces that form between DsRed polypeptides. Amino acids suspected of contributing to oligomerization were replaced by amino acids that are likely to reduce oligomerization.
Crystal structures of DsRed reveal residues that may be involved in tetramerization. The region that we have designated the “hydrophobic interface” primarily engages in hydrophobic interactions that exclude the solvent (
Two considerations guided selection of residues to be mutated and the specific substitutions to be tested. First, certain residues are more likely than others to make a significant energetic contribution to oligomerization. For example, a statistical study revealed that isoleucine side chains are often important for protein-protein interactions (Bogan and Thorn, 1998). In designing the variants of the present invention, it was assumed that surface-exposed hydrophobic residues are likely to promote oligomerization, and therefore, such residues were considered prime candidates for mutagenesis. Thus, it is likely that generation of a stable monomer requires modification of residues Ile-180 and Ile-125 (
In some polypeptide variants, mutations in two of the tetramerization interfaces resulted in a loss of tetramerization, which can be measured in vitro or in vivo as described in the Examples, and loss of fluorescence. It was, therefore, speculated that tetramerization may be important for fluorescence in wild-type DsRed, possibly because the autocatalytic formation of the chromophore may stabilize the folded structure of DsRed or because oligomerization may increase the quantum yield.
To restore fluorescence to an oligomerization-disrupted or monomeric DsRed variants, site-directed mutagenesis was performed to introduce specific changes that were expected to stabilize the immature and/or mature forms of the protein. Two general classes of mutations were introduced in an attempt to restore fluorescence after disrupting the tetramer: (1) mutations that may stabilize folding intermediates to permit the protein to mature even in the absence of oligomerization; and (2) mutations expected to rigidify mature DsRed to enhance quantum yield.
In a second strategy to restore fluorescence to an oligomerization-disrupted or monomeric DsRed variant, a wide range of mutations were introduced into either the entire DsRed coding sequence or into a selected segment of the coding sequence. The variants thus generated were screened for improved fluorescence.
The effect of various mutations has, in some cases, been demonstrated, and in other cases, has been presumed or inferred. The mutations can be divided into the following six categories of effects:
An example of a DsRed monomeric variant containing numerous mutations and identified as DsRed.M1 (SEQ ID NO:5) is described below. Of course, useful monomeric variants of the presently claimed invention having fewer mutations than those contained in the DsRed.M1 may be developed using the guidance and teaching herein of this disclosure.
DsRed.M1 was further modified by introducing D6N, a reversion to the native sequence, in order to reduce the number of acidic residues at the N-terminus. The additional substitutions K121H, K168E, D169G, D115G, and G116N were made to improve brightness or fluorescence.
Once a DsRed monomeric variant having desirable characteristics is identified, one may, of course, use any polynucleotide sequence encoding the variant to express the variant. For example, the polynucleotide encoding the variant may be modified for optimal expression in a particular organism in view of the preferred codon usage of that organism. The polynucleotide may be operably linked to an inducible or constituitive promoter functional in the intended cell or organism. The polynucleotide may be linked in-fram to a second polynucleotide sequence encoding a polypeptide of interest to form a sequence encoding a fusion protein in which the polypeptide of interest is labeled with the DsRed monomeric variant at its N- or C-terminus.
Selection of Amino Acid Substitutions to Reduce Tetramerization
Site-directed mutagenesis using standard methods well-known to one of ordinary skill in the art was used to disrupt the two tetramerization interfaces of DsRed. Various substitutions at each position were made, and fluorescence was evaluated as described below.
The Hydrophobic Interface
Extensive mutagenesis of the hydrophobic interface was performed, beginning with the DsRed.T4 variant. DsRed.T4 contains a T21S substitution. In addition, Met-182, Ile-180, Val-96 and Ile-125 were substituted with more polar residues, and a hydrogen-bonding residue was removed through an S131A substitution. The DsRed.T4 variant having these substitutions was designated DsRed.D1. This variant is probably dimeric. An additional V104A substitution is tolerated in the DsRed.D1 background. It is of note that, in the related fluorescent protein HcRed, a single Leu-to-His mutation in the putative hydrophobic interface at the position corresponding to Ile-125 of DsRed was reportedly sufficient to convert HcRed into a dimer (Gurskaya et al., 2001). Bacterial colonies producing DsRed.D1 are somewhat less fluorescent than those producing DsRed.T4, but the signal with DsRed.D1 is still strong.
The Polar Interface
Initial attempts to mutagenize the polar interface yielded reduced the fluorescence. For example, Leu-174 forms hydrophobic interactions with the opposing subunit, but all of the Leu-174 substitutions that we initially tried, including a conservative change to Val, virtually abolished fluorescence. It was thus concluded that Leu-174 is required for fluorescence and should not be mutated. Similar results were obtained with His-162, which associates with its counterpart on the opposing subunit in an unusual stacking interaction, and with His-222, which inserts into a groove in the opposing subunit. Conservative mutations of these His residues to Ser or Asn severely diminished the fluorescence. Indeed, mutagenesis of most the key residues at the polar interface were found to impair fluorescence.
Assessing Oligomeric State of DsRed Variants
The oligomeric state of a DsRed variant may be assessed by nondenaturing SDS-PAGE or size exclusion chromatography.
For nondenaturing SDS-PAGE, one μg of each purified DsRed variant or wild-type DsRed was mixed with SDS-containing sample buffer on ice and immediately electrophoresed at 4° C. in a 10% polyacrylamide gel, followed by staining with Coomassie Blue. Additional aliquots of of wild-type DsRed and DsRed variants were denatured by boiling prior to electrophoresis.
Gel filtration chromatography may be used to indicate whether a fluorescent protein exists predominantly as a monomer, dimer or tetramer (Gurskaya et al., 2001). Optionally, gel filtration will be conducted using the Pharmacia FPLC system. An extension of this method known as small-zone size-exclusion gel filtration chromatography could be used to measure association constants (Raffen and Stevens, 1999).
Oligomerization states and association constants of our DsRed variants may be evaluated using analytical ultracentrifugation (Laue and Stafford, 1999). This approach was used by Baird et al. (2000) for their initial demonstration that DsRed is a tetramer. A Beckman XL-A analytical ultracentrifuge will be used. Velocity sedimentation will be used to ascertain which DsRed species are present (monomers, dimers and/or tetramers), and then equilibrium sedimentation will be used to measure the oligomer association constants (Laue and Stafford, 1999).
Analytical ultracentrifugation will be carried out in collaboration with Borries Demeler (University of Texas Health Sciences Center at San Antonio}, who has extensive experience with analytical ultracentrifugation (e.g., Demeler and Saber, 1998) and is the author of the state-of-the-art UltraScan II software(http://www.ultrascan.uthscsa.edu).
An in vivo assay for DsRed oligomerization may be used in a genetic screen. For example, a yeast two-hybrid system such as that reported to have has been used to verify the oligomerization of wild-type DsRed (Baird et al., 2000) may be used to assess the tendancy of DsRed variants to oligomerize.
Another approach used to monitor DsRed oligomerization in vivo was to fuse GFP or DsRed to the protein Gos1p in S. cerevisiae. Gos1p is a membrane protein anchored to the cytoplasmic face of yeast Golgi cisternae. The GFP-Gos1p fusion protein gives a fluorescence pattern that is typical for the Golgi in S. cerevisiae, whereas a wild-type DsRed Gos1p fusion generates large red blobs in the cells, presumably because multiple Golgi cisternae become crosslinked via DsRed tetramerization. Thus, visualizing DsRed-Gos1p fusions provides an in vivo assay for DsRed oligomerization.
In another screening assay, randomly mutagenized DsRed proteins will be fused to the C-terminus of glutathione S-transferase (GST; Smith and Johnson, 1988). Because GST is a dimer (McTigue et al., 1995), the fusion of GST to an oligomeric DsRed variant will generate crosslinked aggregates that will be insoluble upon gentle detergent lysis of the cells. By contrast, the fusion of GST to a monomeric DsRed variant will generate a soluble protein. The concept of using this method to evaluate the oligomeric state of DsRed variants was tested using an expression and detergent lysis protocol similar to that used to evaluate solubility or aggregation of DsRed, fluorescent DsRed.T1, a tetrameric variant, was efficiently extracted from the bacterial cells whereas the fluorescent GST-DsRed.T1 was quantitatively retained in the pellet. It is expected that this assay will provide a sensitive screen for a monomeric DsRed.
Optimizing Spectral Properties
In an earlier stage of this project, we attempted to create a bright, red-shifted DsRed variant. We began with DsRed.T4 and introduced a K83M substitution, which had been shown to red-shift the fluorescence spectra of wild-type DsRed (Baird et al., 2000). In the DsRed.T4 background, K83M red-shifted the spectra (
Without being limited as to theory, we speculate that the K83M mutation allows DsRed to tolerate changes at the polar interface by stabilizing the immature form of the DsRed, thereby allowing for correct folding. The cores of most proteins are hydrophobic, but in the case of DsRed, K83 is one of several charged residues that face the interior of the protein (Wall et al., 2000; Yarbrough et al., 2001). It may be that immature DsRed is stabilized by tetramerization, particularly by interactions at the polar interface, and that the K83M substitution renders the immature protein sufficiently stable to fold even in the absence of interactions at the polar interface. Based on this hypothesis, we predict that in the absence of K83M, mutations such as L174Q will decrease the yield of mature DsRed but will not reduce the intrinsic fluorescence of the mature protein. Meanwhile, regardless of the reason, K83M has enabled us to mutagenize the polar interface.
To address the reduced fluorescence found with variants having a K83M substitution, two rounds of random mutagenesis and screening were undertaken. Two additional substitutions (K163H and Y193H) that significantly increase the brightness of the purified protein were identified. These new mutations are distinct from L174Q, and they alter residues that face the interior of the protein. The variant of DsRed.T4 having the K83M, K163H, and Y193H substitutions was designated DsRed.T6. As judged by colony fluorescence, DsRed.T6 is comparable to DsRed.T4 in brightness. Interestingly, the spectral red-shifting observed with K83M is largely reversed by the two additional substitutions in DsRed.T6 (
Preferably, the monomeric DsRed variant of the present invention retains the spectral properties of the tetramer, namely, bright red fluorescence with minimal green emission. However, fluorescent bacterial colonies expressing polypeptides containing substituted amino acids for those of the wild-type DsRed that ordinarily form the hydrophobic tetramerization interface appear somewhat dimmer than colonies of bacteria expressing tetrameric variants. Two kinds of changes may account for decreased fluorescence of the bacterial colonies expressing mutant DsRed. First, a mutation may reduce the intrinsic brightness of DsRed by lowering the extinction coefficient and/or the quantum yield. Second, a mutation might slow DsRed maturation and/or reduce the percentage of the DsRed molecules that eventually become fluorescent. To counteract such effects, random mutagenesis strategy will be used to identify brighter variants of the monomers.
Minimizing the Green Emission of Monomeric DsRed
A predicted side effect of disrupting the DsRed tetramer will be a loss of FRET and a consequent increase in the green emission. To alleviate this problem, mutations that increase the ratio of red to green molecules in mature DsRed may be introduced. Substitutions of K83M, K163H, and Y193H in DsRedT6 correlate with brighter red fluorescence and reduced green emission, relative to that of the DsRed.T4+K83M variant.
In addition to mutations identified in these random screens, directed mutations aimed at weakening the tetramerization may fortuitously reduce the percentage of green molecules in mature DsRed. For instance, the A145P substitution that we incorporated into DsRed.T3 and DsRed.T4 to lower the green emission was originally generated during our attempts to mutagenize the polar interface. More recently, we found that an H222S substitution at the polar interface decreases the green emission.
Screening for Reduced Blue Excitation
Monomeric variants of interest having significant green emission, may be further mutagenized and screened for reduced green emission or reduced blue excitation. A 488-nm laser is used to excite fluorescence in bacteria containing mutant DsRed proteins, and the bacterial cells are then sorted by flow cytometry to identify clones with reduced green emission. This approach would be more difficult with a monomeric DsRed, because undesirable mutations that caused protein aggregation would suppress the green emission due to FRET. Alternatively, mutants may be screened for reduced blue excitation. When total fluorescence is measured, the signal obtained by excitation with blue light should correlate with the percentage of the DsRed molecules having a green fluorophore, regardless of whether the emission spectrum has been modified by FRET.
The assay for reduced blue excitation is based on our standard slide projector method, except that the plates will be photographed with a digital camera. We will photograph each plate under two conditions. First, the total fluorescence after excitation with blue light will be recorded by illuminating through a 485±11 nm bandpass filter and capturing the emission signal through a Kodak Wratten filter #12, which passes wavelengths above 520 nm (Cronin and Hampton, 1999). The image of the plate will be colorized green using Adobe Photoshop. Second, the total fluorescence after excitation with yellow light will be recorded by illuminating through a 520±20 nm bandpass filter and capturing the emission signal through a Kodak Wratten filter #22, which passes wavelengths above 550 nm. This image of the plate will be colorized red. The red image will be due almost exclusively to DsRed molecules with the red fluorophore, whereas the green image will include a strong contribution from DsRed molecules with the green fluorophore. Upon merger of the red and green images, most of the colonies will appear yellow, but colonies having an increased ratio of red to green molecules will appear orange.
One approach to evaluating solubilities of the fluorescent proteins in is as follows. E. coli cells carrying inducible expression vectors encoding hexahistidine-tagged wild-type DsRed or DsRed variants were grown to an optical density (OD) (λ=600 nm) of 0.5, induced for 7 h, lysed with B-PER II detergent (Pierce) and centrifuged for 20 min at 27,000×g. Equivalent amounts of the pellet and supernatant fractions were subjected to SDS PAGE followed by immunoblotting with an anti-hexahistidine antibody. The percentage of each protein in the supernatant fraction was then quantified for each protein and the percentage of protein molecules extracted (i.e., solubilized) was determined. Typically, only about 25% of the wild-type DsRed molecules are solubilized. Suitably, at least 30% of DsRed variant molecules are solubilized. Preferably, at least 50% of DsRed variant molecules are solubilized. More preferably, at least 70% of DsRed variant molecules are solubilized.
Another approach to evaluate variants for reduced aggregation is by nondenaturing SDS-PAGE. One μg of each purified DsRed variant was mixed with SDS-containing sample buffer on ice and immediately electrophoresed at 4° C. in a 10% polyacrylamide gel, followed by staining with Coomassie Blue. Additional aliquots of of wild-type DsRed and DsRed variants were denatured by boiling prior to electrophoresis. Migration of proteins as a diffuse band that may reflect the formation of higher-order oligomers, whereas formation of a sharp band or bands of the appropriate size suggests reduce aggregation.
Creation and Characterization of a Red Fluorescent DsRed Monomer
A coding sequence and the amino acid sequence of one mutant according to the present invention, designated DsRed.M1, is shown as SEQ ID NO:4 and SEQ ID NO:5, respectively. DsRed.M1 contains the following 37 substitutions relative to DsRed.T4:
*A2D is a second mutation of residue 2, which was an arginine in wild-type DsRed.
Oligomeric State: DsRed.M1 behaves functionally as a monomer. The protein appears to be monomeric as judged by nondenaturing SDS-PAGE or size exclusion chromatography.
Brightness: The DsRed.M1 mature protein exhibits detectable red fluorescence, but is less bright than tetrameric variants, such as DsRed.T4. DsRed.M1 is also less bright than a monomeric red fluorescent DsRed protein designated mRFP1, which was generated by Tsien et al. (US 2003/0170911 A1)
Spectral Properties: In contrast to mRFP1, which has a red-shift, DsRed.M1 has excitation and emission spectra similar to those of the tetrameric DsRed variants. Surprisingly, DsRed.M1 has negligible green emission. The lack of green emission is fortunate, and rather unexpected, given that the tetrameric DsRed variants exhibit green emission that is largely suppressed by intersubunit resonance energy transfer.
Photostability: mRFP1 photobleaches much faster than the tetrameric DsRed variants, an effect that may correlate with the altered spectral properties of mRFP1. It is expected that DsRed.M1 will be more photostable than mRFP1 because the spectral properties of DsRed.M1 are similar to those of the tetrameric variants.
Maturation: DsRed.M1 appears to retain the rapid maturation of the parental DsRed.T4, which is considerably faster than that wild-type of DsRed.
Each publication cited in herein or in the appendix is incorporated by reference in its entirety. Also incorporated by reference in its entirety is WO 03/054158A2.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US972638||Dec 3, 1909||Oct 11, 1910||Frederick N Pease||Metal-polish.|
|US4302536||Aug 15, 1978||Nov 24, 1981||Longenecker Robert W||Colorimetric immunoassay process|
|US4399216||Feb 25, 1980||Aug 16, 1983||The Trustees Of Columbia University||Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials|
|US4551433||Jan 11, 1982||Nov 5, 1985||Genentech, Inc.||Microbial hybrid promoters|
|US4560655||Dec 16, 1982||Dec 24, 1985||Immunex Corporation||Serum-free cell culture medium and process for making same|
|US4657866||Sep 13, 1984||Apr 14, 1987||Sudhir Kumar||Serum-free, synthetic, completely chemically defined tissue culture media|
|US4683195||Feb 7, 1986||Jul 28, 1987||Cetus Corporation||Process for amplifying, detecting, and/or-cloning nucleic acid sequences|
|US4683202||Oct 25, 1985||Nov 27, 1990||Cetus Corp||Title not available|
|US4745051||May 27, 1983||May 17, 1988||The Texas A&M University System||Method for producing a recombinant baculovirus expression vector|
|US4767704||Oct 7, 1983||Aug 30, 1988||Columbia University In The City Of New York||Protein-free culture medium|
|US4837148||Oct 30, 1984||Jun 6, 1989||Phillips Petroleum Company||Autonomous replication sequences for yeast strains of the genus pichia|
|US4927762||Nov 30, 1988||May 22, 1990||Cell Enterprises, Inc.||Cell culture medium with antioxidant|
|US4929555||Oct 19, 1987||May 29, 1990||Phillips Petroleum Company||Pichia transformation|
|US5182202||Aug 5, 1991||Jan 26, 1993||Kikkoman Corporation||Purified luciferase from luciola cruciata|
|US5221623||Jul 19, 1989||Jun 22, 1993||Boyce Thompson Institute For Plant Research, Inc.||Use of bacterial luciferase structural genes for cloning and monitoring gene expression in microorganisms and for tagging and identification of genetically engineered organisms|
|US5229285||Jun 23, 1992||Jul 20, 1993||Kikkoman Corporation||Thermostable luciferase of firefly, thermostable luciferase gene of firefly, novel recombinant dna, and process for the preparation of thermostable luciferase of firefly|
|US5330906||Jun 15, 1993||Jul 19, 1994||Kikkoman Corporation||Mutant luciferase of a firefly|
|US5418155||Dec 14, 1993||May 23, 1995||University Of Georgia Research Foundation, Inc.||Isolated Renilla luciferase and method of use thereof|
|US5439797||Aug 30, 1993||Aug 8, 1995||The Regents Of The University Of California||Detection of analytes using fluorescent energy transfer|
|US5484956||Apr 11, 1990||Jan 16, 1996||Dekalb Genetics Corporation||Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin|
|US5491084||Sep 10, 1993||Feb 13, 1996||The Trustees Of Columbia University In The City Of New York||Uses of green-fluorescent protein|
|US5538879||Mar 3, 1993||Jul 23, 1996||Institut Fur Genbiologische Forschung Berlin Gmbh||Expression cassette and plasmids for a guard cell specific expression and their use for the introduction of transgenic plant cells and plants|
|US5576198||Dec 14, 1993||Nov 19, 1996||Calgene, Inc.||Controlled expression of transgenic constructs in plant plastids|
|US5595896||May 3, 1993||Jan 21, 1997||New York University||Expression of heterologous genes in transgenic plants and plant cells using plant asparagine synthetase promoters|
|US5618722||Apr 20, 1994||Apr 8, 1997||Chisso Corporation||Photuris firefly luciferase gene|
|US5629470||Jan 20, 1995||May 13, 1997||Rutgers, The State University Of New Jersey||Transgenic plants and plant cells with enhanced pathogen resistance and related methods|
|US5633155||Jan 18, 1995||May 27, 1997||Jinro Limited||Expression vector for phytolacca antiviral protein and process for preparing transgenic plant transformed therewith|
|US5641670||May 13, 1994||Jun 24, 1997||Transkaryotic Therapies, Inc.||Protein production and protein delivery|
|US5650135||Jul 1, 1994||Jul 22, 1997||The Board Of Trustees Of The Leland Stanford Junior University||Non-invasive localization of a light-emitting conjugate in a mammal|
|US5654173||Aug 23, 1996||Aug 5, 1997||Genetics Institute, Inc.||Secreted proteins and polynucleotides encoding them|
|US5656466||Oct 6, 1994||Aug 12, 1997||Jinro Limited||Process for preparing virus-resistant transgenic plant|
|US5674713||Jun 2, 1995||Oct 7, 1997||The Regents Of The University Of California||DNA sequences encoding coleoptera luciferase activity|
|US5674731||Apr 27, 1995||Oct 7, 1997||Life Technologies, Inc.||Regeneration of both plant tissues and transgenic plant tissues using a new plant hormone, 5-bromoindole-3-acetic acid|
|US5688648||Dec 19, 1995||Nov 18, 1997||The Regents Of The University Of California||Probes labelled with energy transfer coupled dyes|
|US5689045||Jun 1, 1995||Nov 18, 1997||Max-Planck Gesellschaft Zur Forderung Der Wissenschaften||Transgenic pathogen-resistant plant|
|US5689049||Jun 7, 1995||Nov 18, 1997||Pioneer Hi-Bred International, Inc.||Transgenic plant and method for producing male sterility using anther specific promoter 5126|
|US5700673||Jun 2, 1995||Dec 23, 1997||The Regents Of The University Of California||Recombinantly produced Coleoptera luciferase and fusion proteins thereof|
|US5728528||Sep 20, 1995||Mar 17, 1998||The Regents Of The University Of California||Universal spacer/energy transfer dyes|
|US5733761||May 26, 1995||Mar 31, 1998||Transkaryotic Therapies, Inc.||Protein production and protein delivery|
|US5739409||Jun 7, 1995||Apr 14, 1998||The Regents Of The University Of California||Endogenously sweetened transgenic plant products|
|US5750870||Feb 3, 1995||May 12, 1998||Agritope, Inc.||Plant genetic transformation methods and transgenic plants|
|US5767367||Jan 12, 1995||Jun 16, 1998||Hoechst Aktiengesellschaft||Zea mays (L.) with capability of long term, highly efficient plant regeneration including fertile transgenic maize plants having a heterologous gene, and their preparation|
|US5795737||Sep 22, 1995||Aug 18, 1998||The General Hospital Corporation||High level expression of proteins|
|US5804387||Jan 31, 1997||Sep 8, 1998||The Board Of Trustees Of The Leland Stanford Junior University||FACS-optimized mutants of the green fluorescent protein (GFP)|
|US5824485||Apr 24, 1996||Oct 20, 1998||Chromaxome Corporation||Methods for generating and screening novel metabolic pathways|
|US5843746||Jan 13, 1997||Dec 1, 1998||Kikkoman Corporation||Biotinated firefly luciferase, a gene for biotinated firefly luciferase, a recombinant DNA, a process for producing biotinated luciferase and a bioluminescent analysis method|
|US5863727||May 3, 1996||Jan 26, 1999||The Perkin-Elmer Corporation||Energy transfer dyes with enhanced fluorescence|
|US5866336||Jan 3, 1997||Feb 2, 1999||Oncor, Inc.||Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon|
|US5869255||Jan 30, 1997||Feb 9, 1999||The Regents Of The University Of California||Probes labeled with energy transfer couples dyes exemplified with DNA fragment analysis|
|US5874304||Jan 18, 1996||Feb 23, 1999||University Of Florida Research Foundation, Inc.||Humanized green fluorescent protein genes and methods|
|US5911952||Apr 24, 1998||Jun 15, 1999||Hamamatsu Photonics K.K.||Instrument for measuring fluorescence resonance energy transfer|
|US5919445||Jun 17, 1997||Jul 6, 1999||Council Of Agriculture Executive Yuan||Use of green fluorescent protein to trace the infection of baculovirus in insects and to increase viral UV stability|
|US5945283||Dec 17, 1996||Aug 31, 1999||Washington University||Methods and kits for nucleic acid analysis using fluorescence resonance energy transfer|
|US5945526||Mar 23, 1998||Aug 31, 1999||Perkin-Elmer Corporation||Energy transfer dyes with enhanced fluorescence|
|US5958713||Mar 14, 1997||Sep 28, 1999||Novo Nordisk A/S||Method of detecting biologically active substances by using green fluorescent protein|
|US5968738||Dec 6, 1996||Oct 19, 1999||The Board Of Trustees Of The Leland Stanford Junior University||Two-reporter FACS analysis of mammalian cells using green fluorescent proteins|
|US5968750||Oct 9, 1998||Oct 19, 1999||The University Of Florida Research Foundation Inc.||Humanized green fluorescent protein genes and methods|
|US5976796||Dec 23, 1996||Nov 2, 1999||Loma Linda University||Construction and expression of renilla luciferase and green fluorescent protein fusion genes|
|US5981200||Jan 31, 1997||Nov 9, 1999||The Regents Of The University Of California||Tandem fluorescent protein constructs|
|US5985577||Oct 14, 1998||Nov 16, 1999||The Trustees Of Columbia University In The City Of New York||Protein conjugates containing multimers of green fluorescent protein|
|US5989835||Feb 27, 1997||Nov 23, 1999||Cellomics, Inc.||System for cell-based screening|
|US5998146||Jul 17, 1998||Dec 7, 1999||Wallac Oy||Homogeneous luminescence assay method based on energy transfer|
|US6008373||Jun 7, 1995||Dec 28, 1999||Carnegie Mellon University||Fluorescent labeling complexes with large stokes shift formed by coupling together cyanine and other fluorochromes capable of resonance energy transfer|
|US6020192||Jul 16, 1997||Feb 1, 2000||University Of Florida||Humanized green fluorescent protein genes and methods|
|US6066476||Nov 20, 1996||May 23, 2000||The Regents Of The University Of California||Modified green fluorescent proteins|
|US6130313||Apr 17, 1998||Oct 10, 2000||Clontech Laboratories, Inc.||Rapidly degrading GFP-fusion proteins|
|US6306600||Jul 30, 1999||Oct 23, 2001||Clontech Laboratories, Inc.||Rapidly degrading GFP-fusion proteins and methods of use|
|US6707804||Dec 5, 2000||Mar 16, 2004||Tantiuity Communications, Inc.||Fast acquisition of traffic channels for a highly variable data rate reverse link of a CDMA wireless communication system|
|US20020197676||Dec 4, 2001||Dec 26, 2002||Lukyanov Sergey A.||Novel chromophores/fluorophores and methods for using the same|
|US20030059835||Apr 10, 2002||Mar 27, 2003||Tsien Roger Y.||Monomeric and dimeric fluorescent protein variants and methods for making same|
|US20030170911||Feb 26, 2001||Sep 11, 2003||Tsien Roger Y.||Non-oligomerizing fluorescent proteins|
|US20050149994||May 11, 2004||Jul 7, 2005||The University Of Chicago||Rapidly maturing fluorescent proteins and methods for using the same|
|USRE30985||Feb 6, 1981||Jun 29, 1982||Serum-free cell culture media|
|DE19718640A1||May 2, 1997||Jul 22, 1999||Joerg Wiedenmann||Protein derived from Anemonia useful in gene technology and molecular biology|
|EP0036776A2||Mar 23, 1981||Sep 30, 1981||Genentech, Inc.||A method of creating an expression plasmid|
|EP0127839A2||May 22, 1984||Dec 12, 1984||THE TEXAS A&M UNIVERSITY SYSTEM||Method for producing a recombinant baculovirus expression vector|
|EP0155476A1||Jan 31, 1985||Sep 25, 1985||Idaho Research Foundation||Production of polypeptides in insect cells|
|EP0244234A2||Apr 29, 1987||Nov 4, 1987||Alko Group Ltd.||Transformation of trichoderma|
|WO1987000195A1||Jun 30, 1986||Jan 15, 1987||Celltech Limited||Animal cell culture|
|WO1990003430A1||Sep 13, 1989||Apr 5, 1990||Cetus Corporation||Cell culture medium for enhanced cell growth, culture longevity and product expression|
|WO1990004036A1||Oct 12, 1989||Apr 19, 1990||Medical Research Council||Production of antibodies from transgenic animals|
|WO1990010077A1||Feb 22, 1990||Sep 7, 1990||Celltech Limited||Vector for integration site independent gene expression in mammalian host cells|
|WO1991000357A1||Jun 28, 1990||Jan 10, 1991||Cayla||New strain with filamentous fungi mutants, process for the production of recombinant proteins using said strain, and strains and proteins produced by said process|
|WO1992002190A1||Aug 9, 1991||Feb 20, 1992||Silverman Harvey N||Method and system for whitening teeth|
|WO1999015650A1||Sep 25, 1998||Apr 1, 1999||Athersys, Inc.||Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna|
|WO1999049019A2||Mar 26, 1999||Sep 30, 1999||Prolume, Ltd.||Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics|
|WO2000002997A2||Jul 8, 1999||Jan 20, 2000||Wisconsin Alumni Research Foundation||Transgenic mouse expressing green fluorescent protein in astrocytes|
|WO2000003246A2||Jul 13, 1999||Jan 20, 2000||Cellomics, Inc.||A system for cell-based screening|
|WO2000017624A2||Sep 22, 1999||Mar 30, 2000||Cellomics, Inc.||Miniaturized cell array methods and apparatus for cell-based screening|
|WO2000017643A2||Sep 17, 1999||Mar 30, 2000||Cellomics, Inc.||A system for cell-based screening|
|WO2000026408A2||Oct 29, 1999||May 11, 2000||Cellomics, Inc.||A system for cell-based screening|
|WO2000046233A1||Feb 2, 2000||Aug 10, 2000||The University Of Sydney||Pigment protein from coral tissue|
|WO2001027150A2||Oct 13, 2000||Apr 19, 2001||Clontech Laboratories Inc.||Anthozoa derived chromo/fluoroproteins and methods for using the same|
|WO2002040539A2||Oct 16, 2001||May 23, 2002||Curagen Corporation||Gpcr-like protein and nucleic acids encoding same|
|WO2002068459A2||Feb 20, 2002||Sep 6, 2002||Clontech Laboratories, Inc.||Non aggregating fluorescent proteins and methods for using the same|
|WO2003054158A2||Dec 18, 2002||Jul 3, 2003||The University Of Chicago||Rapidly maturing fluorescent proteins and methods for using the same|
|1||"IUPAC-IUB Commission on Biochemical Nomenclature a One-Letter Notation for Amino Acid Sequences Tentative Rules," J. Biol. Chem. (1968) 243(13):3557-3559.|
|2||Altschul, S.F. et al., "Basic Local Alignment Search Tool," J. Mol. Biol. (1990) 215:403-410.|
|3||Anderluh, G. et al., "Cloning, Sequencing, and Expression of Equinatoxin II," Biochem. Biophys. Res. Comm. (1996) 220:437-442.|
|4||Animal Cell Culture, a practical approach, R.I. Freshney, ed., IRL Press, Oxford-Washington DC, (1986) (Book-Not Provided/Table of Contents Only).|
|5||Atwell, S. et al., "Structural Plasticity In A Remodeled Protein-Protein Interface," Science (1997) 278:1125-1128.|
|6||Baird, G.S. et al., "Biochemistry, Mutagenesis, and Oligomerization of DsRed, a Red Fluorescent Protein From Coral," Proc. Natl. Acad. Sci. USA (2000) 97:11984-11989.|
|7||Ballance, D.J. et al., "Transformation of Apergillus Nidulans by the Orotidine-5'-Phosphate Decarboxylase Gene of Neurospora Crassa," Biochem. Biophys. Res. Commun. (1983) 112(1):284-289.|
|8||Barton, M.C. et al., "Site-Directed, Recombination-Mediated Mutagenesis of a Complex Gene Locus," Nucleic Acids Res. (1990) 18(24):7349-7355.|
|9||Beach, D. et al., "Functionally Homologous Cell Cycle Control Genes in Budding and Fission Yeast," Nature (1981) 300:706-709.|
|10||Beernink, P.T. et al., "Disruption Of The Aldolase a Tetramer into Catalytically Active Monomers," Proc. Natl. Acad. Sci. USA (1996) 93:5374-5379.|
|11||Bevis, B.J. et al., "Rapidly Maturing Variants of the Discosoma Red Fluorescent Protein (DsRed)," Nat. Biotechnol. (2002) 20:83-87.|
|12||Bogan, A.A. et al., "Anatomy of Hot Spots in Protein Interfaces," J. Mol. Biol. (1998) 280:1-9.|
|13||Boshart, M. et al., "A Very Strong Enhancer is Located Upstream of an Immediate Early Gene of Human Cytomegalovirus," Cell (1985) 41:521-530.|
|14||Cadwell, R.C. et al., "Mutagenic PCR," PCR Primer. A Laboratory Manual (1995) Dieffenbach and Dveksler, eds., Cold Spring Harbor Laboratory Press, 583-589.|
|15||Campbell, R.E. et al., "A Monomeric Red Fluorescent Protein," Proc. Natl. Acad. Sci. USA (2002) 99(12):7877-7882.|
|16||Carbonell, L.F. et al., "Synthesis of a Gene Coding for an Insect-Specific Scorpion Neurotoxin and Attempts to Express it Using Baculovirus Vectors," Gene (1988) 73:409-418.|
|17||Colicelli, J. et al., "A Temperature-Sensitive Mutation Constructed by 'Linker Insertion' Mutagenesis," Mol. Gen. Genet. (1985) 199:537-539.|
|18||Condeelis, J.S. et al., "Imaging of Cancer Invasion and Metastasis Using Green Fluorescent Protein," Eur. J. Cancer (2000) 36:1671-1680.|
|19||Cormack, B.P. et al., "FACS-optimized Mutants of the Green Fluorescent Protein (GFP)," Gene (1996) 173:33-38.|
|20||Cregg, J.M. et al., "Pichia Pastoris as a Host System for Transformations," Mol. Cell Biol. (1985) 5(12):3376-3385.|
|21||Cronin, S. et al., "A Genetics-Friendly GFP Assay," Trends Cell Biol. (1999) 9:36.|
|22||Cubitt, A.B. et al., "Understanding Structure-Function Relationships in the Aequoria victoria Green Fluorescent Protein," Methods in Cell Biology (1999), Sullivan and Kay, eds, Academic Press, San Diego, 58:19-30.|
|23||Das, S. et al., "Transformation of Kluyveromyces fragilis," J. Bacteriol. (1984) 158(3):1165-1167.|
|24||Davidow, L.S. et al., "Integrative Transformation of the Yeast Yarrowia lipolytica," Curr. Genet. (1985) 10:39-48.|
|25||De Boer, H.A. et al., "The tac Promoter: A Functional Hybrid Derived from the trp and lac Promoters," Proc. Natl. Acad. Sci. USA (1983) 80:21-25.|
|26||De Giorgi, F. et al., "Targeting GFP to Organelles," Methods in Cell Biology (1999), Sullivan and Kay, eds., Academic Press, San Diego, 58:75-85.|
|27||De Louvencourt, L. et al., "Transformation of Kluyveromyces lactis by Killer Plasmid DNA," J. Bacteriol. (1983) 154(2):737-742.|
|28||Demeler, B. et al., "Determination of Molecular Parameters by Fitting Sedimentation Data to Finite-element Solutions of the Lamm Equation," Biophys. J. (1998) 74:444-454.|
|29||Deo, S.K. et al., "Luminescent Proteins from Aequorea victoria: Applications in Drug Discovery and in High Throughput Analysis," Fresenius J. Anal. Chem. (2001) 369:258-266.|
|30||Dickson, R.M. et al., "On/Off Blinking and Switching Behavior of Single Molecules of Green Fluorescent Protein," Nature (1997) 388:355-358.|
|31||Dijkema, R. et al., "Cloning and Expression of the Chromosomal Immune Interferon Gene of the Rat," EMBO J. (1985) 4(3):761-767.|
|32||Dittrich, P. et al., "Accessing Molecular Dynamics in Cells by Fluorescence Correlation Spectroscopy," Biol. Chem. (2001) 382:491-494.|
|33||DNA Cloning: A Practical Approach, vol. I and II (D.N. Glover ed), IRL Press Oxford-Washington DC (1985) (Book Not Provided/Table of Contents Only).|
|34||Dove, S.G. et al., "Isolation and Partial Characterization of the Pink and Blue Pigments of Pocilloporid and Acroporid Corals," Biol. Bull. (1995) 189:288-297.|
|35||Ellenberg, J. et al., "Dual-color Imaging with GFP Variants," Trends Cell Biol.(1999) 9:52-56.|
|36||Fischer, M. et al., "A Brilliant Monomeric Red Fluorescent Protein to Visualize Cytoskeleton Dynamics in Dictyostelium," FEBS Letters, (2004) 577:227-232.|
|37||Fradkov, A.F. et al., "Novel Fluorescent Protein from Discosoma Coral and its Mutants Possesses a Unique Far-Red Fluorescence," FEBS Lett. (2000) 479:127-130.|
|38||Friesen, P.D. et al., "The Regulation of Baculovirus Gene Expression," Current Topics in Microbiology and Immunology, W. Doerfler, ed., Springer-Verlag Berlin-Heidelberg (1986) 131:31-49.|
|39||Garcia-Parajo, M.F. et al., "The Nature of Fluorescence Emission in the Red Fluorescent Protein DsRed, Revealed by Single-Molecule Detection," Proc. Natl. Acad. Sci. USA (2001) 98:14392-14397.|
|40||Garcia-Parajo, M.F. et al., "Visualizing Individual Green Fluorescent Proteins with a Near Field Optical Microscope," Cytometry (1999) 36:239-246.|
|41||Gleeson, M.A. et al., "Transformation of the Methylotrophic Yeast Hansenula polymorpha," J. Gen. Microbiol. (1986) 132:3459-3465.|
|42||Goeddel, D.V. et al., "Direct Expression in Escherichia coli of a DNA Sequence Coding for Human Growth Hormone," Nature (1979) 281:544-548.|
|43||Goeddel, D.V. et al., "Synthesis of human fibroblast interferon by E. coli," Nucleic Acids Res. (1980) 8:4057-4073|
|44||Gorman, C.M. et al., "The Rous Sarcoma Virus Long Terminal Repeat is a Strong Promoter when Introduced into a Variety of Eukaryotic Cells by DNA-Mediated Transfection," Proc. Natl. Acad. Sci. USA (1982) 79:6777-6781.|
|45||Gross, L.A. et al., "The Structure of the Chromophore Within DsRed, A Red Fluorescent Protein from Coral," Proc. Natl. Acad. Sci. USA (2000) 97:11990-11995.|
|46||Grosschedl, R. et al., "Cell-type Specificity of Immunoglobulin Gene Expression in Regulated by at Least Three DNA Sequence Elements," Cell (1985) 41:885-897.|
|47||Guide to Protein Purification, Deutscher, ed., Academic Press (1990) (Book Not Provided/Table of Contents Only).|
|48||Gurskaya, N.G. et al., "Color Transistions in Coral's Fluorescent Proteins by Site-Directed Mutagenesis," BMC Biochem. (2001) 2:6.|
|49||Gurskaya, N.G. et al., "GFP-like Chromoproteins as a Source of Far-red Fluorescent Proteins," FEBS Lett. (2001) 507:16-20.|
|50||Gustin, K.E. et al., "A Rapid Method for Generating Linker Scanning Mutants Utilizing PCR," Biotechniques (1993) 14:22-23.|
|51||Harms, G.S. et al., "Autofluorescent Proteins in Single-Molecule Research: Applications to Live Cell Imaging Microscopy," Biophys. J. (2001) 80:2396-2408.|
|52||Harvey, E.N., Bioluminescence, New York, Academic Press (1952) (Book Not Provided/Table of Contents Only).|
|53||Hastings, J.W., "Bioluminescence," Cell Physiology (1995) , N. Speralakis, ed, New York, Academic Press, 665-681.|
|54||Haugwitz, M. et al., "Characterization of the Improved Red Fluorescent Protein DsRed2," Soc. for Neuroscience Abstracts(2001) 27(1):351 (XP002305478).|
|55||Hawley, T.S. et al., "Four-color Flow Cytometric Detection of Retrovirally Expressed Red, Yellow, Green, and Cyan Fluorescent Proteins," BioTechniques (2001) 30:1028-1034.|
|56||Heim, R. et al., "Engineering Green Fluorescent Protein for Improved Brightness, Longer Wavelengths and Fluorescent Resonance Energy Transfer," Curr. Biol. (1996) 6:178-182.|
|57||Heim, R. et al., "Improved Green Fluorescence," Nature (1995) 373:663-664.|
|58||Higgins, D.G. et al., "Fast and Sensitive Multiple Sequence Alignments on a Microcomputer," CABIOS Comm. (1989) 5(2):151-153.|
|59||Hinnen, A. et al., "Transformation of Yeast," Proc. Natl. Acad. Sci. USA (1978) 75(4):1929-1933.|
|60||Hu, J.C., "Repressor Fusions as a Tool to Study Protein-Protein Interactions," Structure (1995) 3:431-433.|
|61||Immobilised Cells and Enzymes, a Practical Approach, J. Woodward, ed., IRL Press, Oxford-Washington DC (1986) (Book Not Provided/Table of Contents Only).|
|62||Ito, H. et al., "Transformation of Intact Yeast Cells Treated with Alkali Cations," J. Bacteriol. (1983) 153(1):163-168.|
|63||Jakobs, S. et al., "EGFP and DsRed Expressing Cultures of Escherichia coli Imaged by Confocal, Two-Photon And Fluorescence Lifetime Microscopy," FEBS Lett. (2000) 479:131-135.|
|64||Jones, D.H. et al., "Recombinant Circle PCR and Recombination PCR for Site-specific Mutagenesis Without PCR Product Purification," Biotechniques (1992) 12(4):528-533.|
|65||Jost, C.R. et al., "Mammalian Expression and Secretion of Functional Single-chain Fv Molecules," J. Biol. Chem. (1994) 369(42):26267-26273.|
|66||Kabat, E.A. et al., Sequences of Proteins of Immunological Interest (1991) NIH publication No. 91-3242 (Book Not Provided/Table of Contents Only).|
|67||Kelly, J.M. et al., "Transformation of Aspergillus niger by the amdS gene of Aspergillus nidulans," EMBO J. (1985) 4(2):475-479.|
|68||Kilgard, M. et al., "Anticipated Stimuli Across Skin," Nature 373:663.|
|69||Klebanoff, S. et al., "Metabolic Similarities Between Fetilization and Phagocytosis. Conservation of Peroxidatic Mechanism," J. Exp. Med. (1979) 149:938-953.|
|70||Knop, M. et al., "Improved Verison of the Red Fluorescent Protein (drFK583/DSRed/RFP," BioTechniques (2002) 33:3:592, 594, 596-598, 600, 602.|
|71||Kubitscheck, U. et al., "Imaging and Tracking of Single GFP Molecules in Solution," Biophys. J. (2000) 78:2170-2179.|
|72||Kunze, G. et al., "Transformation of the Industrially Important Yeasts Candida maltrosa and Pichia guilliermondii," J. Basic Microbiol. (1985) 25:141-144.|
|73||Kurtz, M.B. et al., "Integrative Ttransformation of Candida albicans, Using a Cloned Candida ADE2 Gene," Mol. Cell Biol. (1986) 6:142-149.|
|74||Laitinen, O.H. et al., "Biotin Induces Tetramerization of a Recombinant Monomeric Avidin. A Model for Protein-Protein Interactions," J. Biol. Chem. (2001) 276:8219-8224.|
|75||Lakowicz, J.R., Principles of Fluorescence Spectroscopy, 2nd Ed., Kluwer Academic/Plenum Publishers, New York (1999) (Book Not Provided/Table of Contents Only).|
|76||Laue, T.M. et al., "Modern Applications of Analytical Ultracentrifugation," Annu. Rev. Biophys. Biomol. Struct. (1999) 28:75-100.|
|77||Lauf, U. et al., "Expression of Fluorescently Tagged Connexins: A Novel Approach to Rescue Function of Oligomeric DsRed-Tagged Proteins," FEBS Lett. (2001) 498-11-15.|
|78||Less, S.H. et al., "Novel Approaches to Monitor Bacterial Gene Expression in Infected Tissue and Host," Curr. Opin. Microbiol. (2000) 3:97-101.|
|79||Liu, A.Y. et al., "Chimeric Mouse-human IgG1 Antibody That Can Mediate Lysis of Cancer Cells," Proc. Natl. Acad. Sci. USA (1987) 84:3439-3443.|
|80||Liu, A.Y. et al., "Production of a Mouse-human Chimeric Monoclonal Antibody to CD20 with Potent Fc-dependent Biologic Activity," J. Immunol. (1987) 139(10):3521-3526.|
|81||Luckow, V.A. et al., "Trends in the Development of Baculovirus Expression Vectors," Bio/Technology (1988) 6:47-55.|
|82||Lukyanov, K. et al., "Natural Animal Coloration Can Be Determined by a Nonfluorescent Green Gluorescent Protein Homolog," J. Biol. Chem. (2000) 275(34):25879-25882.|
|83||Macek, P. et al., "Intrinsic Tryptophan Fluorescence of Equinatoxin II, a Pore-Forming Polypeptide from the Sea Anemone Actinia Equina L, Monitors its Interaction with Lipid Membranes," Eur. J. Biochem. (1995) 234:329-335.|
|84||Maeda, S. et al., "Production of Human alpha-interferon in Silkworm Using a Baculovirus Vector," Nature (1985) 315:592-594.|
|85||Maniatis, T. et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory (1982) (Book Not Provided/Table of Contents Only).|
|86||Marotti, K.R. et al., "Simple and Efficient Oligonucleotide-Directed Mutagenesis Using One Primer and Circular Plasmid DNA Template," Gene Anal. Tech. (1989) 6:67-70.|
|87||Martin, B.M. et al., "Glycosylation and Processing of High Levels of Active Human Glucocerebrosidase in Invertebrate Cells Using a Baculovirus Expression Vector," DNA (1988) 7(2):99-106.|
|88||Martynov, V.I. et al., "Alternative Cyclization in GFP-like Proteins Family," J. Biol. Chem. (2001) 276:21012-21016.|
|89||Matz, M.V. et al., "Fluorescent Proteins from Nonbioluminscent Anthozoa Species," Nat. Biotechnol. (1999) 17:969-973.|
|90||McNew, J.A. et al., "Gos1p, a Saccharomyces cerevisiae SNARE Protein Involved in Golgi Transport," FEBS Lett. (1998) 435:89-95.|
|91||McTigue, M.A. et al., "Crystal Structures of a Schitosomal Drug and Vaccine Target: Flutathion S-Transferase From Schistosoma Japonica and its Complex with the Leading Antischistosomal Drug Praziquantel," J. Mol. Biol. (1995) 246:21-27.|
|92||Miller, D.W. et al.,"An Insect Baculovirus Host-Vector System for High-Level Expression Of Foreigh Genes," Genetic Engineering (1986) 8:277-298.|
|93||Miyajima, A. et al., "Use of the Silkworm, Bombyx Mori, and an Insect Baculovirus Vector for High-Level Expression and Secretion of Biologically Active Mouse Interleukin-3," Gene (1987) 58:273-281.|
|94||Miyawaki, A. et al., "Fluorescent Indicators for Ca<SUP>2+ </SUP>Based on Green Fluorescent Proteins and Calmodulin," Nature (1997) 388:882-887.|
|95||Moerner, W.E. et al., "Optical Methods for Exploring Dynamics of Single Copies of Green Fluorescent Protein," Cytometry (1999) 36:232-238.|
|96||Nucleic Acid Hybridization, a Practical Approach, B.D. Harnes & S.J. Higgins eds., IRL Press, Oxford-Washington DC (1985) (Book Not Provided/Table of Contents Only).|
|97||Okayama, H. et al., "A cDNA Cloning Vector that Permits Expression of Cdna Inserts in Mammalian Cells," Mol. Cell Biol. (1983) 3(2):280-289.|
|98||Oligonucleotide Synthesis, a Practical Approach, M.J. Gait, ed., IRL Press, Oxford-Washington DC (1984) (Book Not Provided/Table of Contents Only).|
|99||Perbal, B., A Practical Guide to Molecular Cloning, John Wiley & Sons, New York (1984) (Book Not Provided/Table of Contents Only).|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7910714||Mar 22, 2011||The University Of Chicago||Monomeric red fluorescent proteins|
|US8679749||Nov 3, 2008||Mar 25, 2014||The University Of Chicago||Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation|
|US8962341||Dec 10, 2009||Feb 24, 2015||The Commonwealth Medical College||Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis|
|US9075045||Jun 6, 2013||Jul 7, 2015||The Commonwealth Medical College||Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis|
|US20100184954 *||Jul 22, 2010||The University Of Chicago||Monomeric red fluorescent proteins|
|US20110020784 *||Nov 3, 2008||Jan 27, 2011||Glick Benjamin S||Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation|
|US20140237632 *||Jan 21, 2014||Aug 21, 2014||The University Of Chicago||Rapidly maturing fluroscent proteins and methods for using the same|
|WO2009059305A2 *||Nov 3, 2008||May 7, 2009||The University Of Chicago||Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation|
|WO2009059305A3 *||Nov 3, 2008||Sep 11, 2009||The University Of Chicago|
|U.S. Classification||435/440, 435/252.3, 435/69.1, 436/172, 435/320.1, 530/802, 536/23.5|
|International Classification||C12Q1/68, C07K14/435, C07H21/04, C12P21/06, C12N15/00|
|Cooperative Classification||Y10S530/802, C07K14/43504, C07K14/43595|
|European Classification||C07K14/435A, C07K14/435A5|
|Sep 16, 2005||AS||Assignment|
Owner name: THE UNIVERSITY OF WASHINGTON, WASHINGTON
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BAKER, DAVID;SCALLEY-KIM, MICHELLE;REEL/FRAME:016544/0616;SIGNING DATES FROM 20050831 TO 20050906
|Jul 31, 2008||AS||Assignment|
Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF
Free format text: CONFIRMATORY LICENSE;ASSIGNOR:UNIVERSITY OF CHICAGO;REEL/FRAME:021320/0026
Effective date: 20051218
|Aug 5, 2008||AS||Assignment|
Owner name: THE UNIVERSITY OF CHICAGO, ILLINOIS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GLICK, BENJAMIN S.;BEVIS, BROOKE;STRONGIN, DANIEL E.;REEL/FRAME:021339/0116;SIGNING DATES FROM 20041123 TO 20041124
|Jan 13, 2011||FPAY||Fee payment|
Year of fee payment: 4
|Jan 21, 2015||FPAY||Fee payment|
Year of fee payment: 8